These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17037315)

  • 1. [Cytokine targetting therapy for inflammatory bowel diseases].
    Matsumoto T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1781-6. PubMed ID: 17037315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of steroid-refractory ulcerative colitis with infliximab].
    Castro Fernández M; García Díaz E; Romero M; Galán Jurado V; Rodríguez Alonso C
    Gastroenterol Hepatol; 2003 Jan; 26(1):54-5. PubMed ID: 12525332
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J
    Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in the management of inflammatory bowel disease.
    Rutgeerts P; Baert F
    Acta Clin Belg; 1999 Oct; 54(5):274-80. PubMed ID: 10555385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].
    Hibi T; Ogata H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):499-504. PubMed ID: 15052810
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
    Hanauer SB
    Gut; 2007 Sep; 56(9):1181-3. PubMed ID: 17698862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for ulcerative colitis.
    Reinshagen M
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575949
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in Pediatric Inflammatory Bowel Disease.
    Maxwell EC; Grossman AB
    Adolesc Med State Art Rev; 2016; 27(1):57-74. PubMed ID: 27363233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of chronic inflammatory intestinal disease].
    Van Gossum A
    Rev Med Brux; 2000 Dec; 21(6):A513-5. PubMed ID: 11194501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological therapies for treatment of chronic inflammatory bowel diseases. Status update].
    Metzler J; Stange EF
    Med Klin (Munich); 2002 May; 97(5):290-7. PubMed ID: 12078390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
    Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
    Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.
    Vos AC; Wildenberg ME; Arijs I; Duijvestein M; Verhaar AP; de Hertogh G; Vermeire S; Rutgeerts P; van den Brink GR; Hommes DW
    Inflamm Bowel Dis; 2012 Mar; 18(3):401-8. PubMed ID: 21936028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
    Sandborn WJ; Hanauer SB
    Inflamm Bowel Dis; 1999 May; 5(2):119-33. PubMed ID: 10338381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 19. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
    Wedekind S
    MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive therapies for inflammatory bowel disease.
    Zenlea T; Peppercorn MA
    World J Gastroenterol; 2014 Mar; 20(12):3146-52. PubMed ID: 24696600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.